Sy Mukherjee, Fortune

Sy Mukherjee


New York, NY, United States

Contact Sy

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Learn more here

  • Fortune

Recent articles by Sy:

The World’s Best-Selling Drug Just Lost a Key Patent Battle

Drug giant AbbVie's Humira is the best-selling drug in the world. It just lost a key patent battle to the small biotech Coherus. → Read More

Johnson & Johnson Unveils Ambitious Multi-Billion Dollar Plan

J&J thinks it can get more than 10 huge-selling drugs to the market by 2021. → Read More

Amazon’s Next Big Disruption May Be the Pharmacy Business

Reports that Amazon is seriously pursuing the pharmacy business hit Walgreens and CVS stock on Wednesday. → Read More

Theranos Just Reached a Deal With Investors to Avoid Lawsuits

Elizabeth Holmes' blood testing firm is vying for redemption. → Read More

More Than 1.2 Million Kids Die Each Year From Preventable Causes

A new World Health Organization report finds that adolescent deaths are driven by auto accidents and suicides. Many are preventable. → Read More

Why Health Care Is Especially Vulnerable to Ransomware Attacks

The global WannaCry cyber attack highlights a frightening reality. → Read More

Why the Companies That Actually Make Your Drugs Are in a Merger Frenzy

Shifts in the biopharma economy have big ripple effects. → Read More

Why Drug Giant AstraZeneca’s Stock Soared More Than 9% on Friday

British pharma giant AstraZeneca's stock soared 9% in Friday trading. The company's key drug posted impressive lung cancer results. → Read More

How Jeff Sessions Could Make the Opioid Epidemic Even Worse

Attorney General Jeff Sessions issued a memo ordering the harshest sentences for criminals. It could make the opioid epidemic worse. → Read More

Judge Puts Another Nail in the $54 Billion Anthem-Cigna Merger’s Coffin

A federal judge has rejected Anthem's request to stop Cigna from ditching the health insurance companies' proposed $54 billion merger. → Read More

Why Merck’s Keytruda Just Became a Lung Cancer Game Changer

A new FDA approval gives Merck a huge advantage over its rivals. → Read More

Blue Cross and Blue Shield Will Give Americans a Free ‘Lyft’ to the Hospital

Lyft and Blue Cross and Blue Shield are launching a national program to provide free medical transport for some BCBS plan holders. → Read More

The U.S. Government Has Issued a Dire Warning on Tuberculosis

Russia, India, and other countries will feel the brunt. → Read More

This Drug Company Just Made a Huge Pledge on Its Prices

Sanofi is going a step further than other drug makers. → Read More

The FDA Has Approved a Crazy Number of New and Groundbreaking Drugs This Year

20 new drugs in 2017 to date. There were just 22 in all of 2016. → Read More

Your Zip Code Is One of the Strongest Indicators of When You’ll Die

A new study finds that U.S. life expectancy oscillates wildly depending on where Americans live. Some counties have a 20-year advantage. → Read More

The FDA Just Approved the First New ALS Drug in 22 Years

It's only the 2nd approved treatment for Lou Gehrig's disease. → Read More

The Biotech IPO Market May Be Headed for a Comeback

After a 2016 lull, the biotech IPO market may be headed for a comeback. Ovid and Biohaven had strong public offerings Thursday. → Read More

Why Trumpcare’s Biggest Fans Are Going to Be Disappointed

House Republicans have finally passed a health care bill repealing and replacing Obamacare. But their rhetoric doesn't match the facts. → Read More

This Simple Cancer Test Comes With a Big Caveat

Information without nuance could be bad for patients. → Read More